-
Linagliptin CAS668270-12-0Approved description: a kind of used in the treatment of type 2 diabetes dipeptide base peptidase 4 (DPP - 4) inhibitors.
1
pagesCopyright © Suzhou Yacoo Science Co., Ltd. All Rights Reserved
Friendly Links :
online service